Population Screening for Genetic Disorders in the 21st Century:Evidence, Economics, and Ethics

导出原文传递

翻译打印收藏纠错

作者： S.D. Grosse ^[1] ; W.H. Rogowski ^[2] ; L.F. Ross ^[3] ; M.C. Cornel ^[4] ; W.J.Dondorp ^[5] ; M.J. Khoury ^[6]

作者单位： eCommunity Genetics Section, Departmentof Clinical Genetics/EMGO Institute, VU University Medical Center (VUMC), Amsterdam ^[1] National Office of Public Health Genomics,Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, Ga., USA ^[2] aNational Center on Birth Defects and Developmental Disabilities U.S. Department of Health and Human Services, Atlanta, Ga., USA ^[3] cHelmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH), Institute of HealthEconomics and Health Care Management, Neuherberg, Germany ^[4] Department of Pediatrics and the MacLean Centerfor Clinical Medical Ethics at the University of Chicago, Chicago, Ill., USA ^[5] Department of Health, Ethics& Society, Faculty of Health, Medicine & Life Sciences, Maastricht University, Maastricht, The Netherlands ^[6]

关键词 Clinical utility Cost-effectiveness ELSI Genetic testing Newborn screening

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交